Minnesota HF 294: Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.

Status: Committee report, to adopt and re-refer to Judiciary Finance and Civil Law (as of 2023-02-15)

State: Minnesota · Session: 2023-2024 · Bill: HF 294

Subjects: Drugs and Medicine, Health and Health Department, Insurance-Health

Sponsors: Elkins, Bahner, Her

View Minnesota HF 294 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.